0001213900-26-005642.txt : 20260120 0001213900-26-005642.hdr.sgml : 20260120 20260120160122 ACCESSION NUMBER: 0001213900-26-005642 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260120 DATE AS OF CHANGE: 20260120 EFFECTIVENESS DATE: 20260120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BiomX Inc. CENTRAL INDEX KEY: 0001739174 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 823364020 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-570448 FILM NUMBER: 26542765 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: 22 EINSTEIN ST. STREET 2: FLOOR 4 CITY: NESS ZIONA PROVINCE COUNTRY: L3 BUSINESS PHONE: 972 723942377 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: 22 EINSTEIN ST. STREET 2: FLOOR 4 CITY: NESS ZIONA PROVINCE COUNTRY: L3 FORMER COMPANY: FORMER CONFORMED NAME: Chardan Healthcare Acquisition Corp. DATE OF NAME CHANGE: 20180430 D 1 primary_doc.xml X0708 D LIVE 0001739174 BiomX Inc. 22 EINSTEIN STREET, FLOOR 4 NESS ZIONA L3 ISRAEL 7414003 +972 723942377 DELAWARE None Chardan Healthcare Acquisition Corp. Corporation true Jonathan Solomon c/o 22 Einstein Street, Floor 4 Ness Ziona L3 ISRAEL 7414003 Executive Officer Director Chief Executive Officer Marina Wolfson c/o 22 Einstein Street, Floor 4 Ness Ziona L3 ISRAEL 7414003 Executive Officer Chief Financial Officer Merav Bassan c/o 22 Einstein Street, Floor 4 Ness Ziona L3 ISRAEL 7414003 Executive Officer Chief Development Officer Susan Blum c/o 22 Einstein Street, Floor 4 Ness Ziona L3 ISRAEL 7414003 Director Jesse Goodman c/o 22 Einstein Street, Floor 4 Ness Ziona L3 ISRAEL 7414003 Director Russell Greig c/o 22 Einstein Street, Floor 4 Ness Ziona L3 ISRAEL 7414003 Director Jonathan Leff c/o 22 Einstein Street, Floor 4 Ness Ziona L3 ISRAEL 7414003 Director Gregory Merril c/o 22 Einstein Street, Floor 4 Ness Ziona L3 ISRAEL 7414003 Director Alan Moses c/o 22 Einstein Street, Floor 4 Ness Ziona L3 ISRAEL 7414003 Director Eddie Williams c/o 22 Einstein Street, Floor 4 Ness Ziona L3 ISRAEL 7414003 Director Pharmaceuticals Decline to Disclose 06b false 2026-01-13 false true true true false 0 H.C. Wainwright & Co., LLC 000000375 None None 430 Park Avenue, Floor 4 New York NY NEW YORK 10022 true 3300000 3300000 0 On January 13, 2026, the Company issued and sold 3,300 shares of Series Y Convertible Preferred Stock and warrants to purchase common stock. The Total Offering Amount excludes proceeds from any conversion of the preferred stock or exercise of the warrants false 1 210000 0 0 false BiomX Inc. /s/ Marina Wolfson Marina Wolfson Chief Financial Officer 2026-01-20